Log in

Relevant bibliographies by topics / Charcot-Marie-Tooth / Journal articles

To see the other types of publications on this topic, follow the link: Charcot-Marie-Tooth.

Journal articles on the topic 'Charcot-Marie-Tooth'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Charcot-Marie-Tooth.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Harris, N. "Charcot-Marie-Tooth." British Dental Journal 206, no. 4 (2009): 187. http://dx.doi.org/10.1038/sj.bdj.2009.124.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dincher, Dr Andrea, and Lena Michelle Dincher. "Effects of Conventional Therapy on Quality Of Life in CMT Disease. Review and Meta-Analysis." International Journal of Medical Science and Clinical Invention 9, no. 07 (2022): 6190–205. http://dx.doi.org/10.18535/ijmsci/v9i07.04.

Full text

Abstract:

Objectives: Up to now, only symptoms of Charcot-Marie-Tooth disease can be treated. This work investigates which therapy is the most effective in Quality of Life in Charcot-Marie-Tooth. Methods: A literature research was conducted (search terms “Whole Body Vibration” or “WBV” or “Exercise” or “Rehabilitation” and “Charcot Marie Tooth” or “CMT” or “Hereditary Neuropathy” or “HMSN”) in five online databases. Inclusion: Publications from January 1990 to April 2022. Exclusion: No conventional treatment or Charcot-Marie-Tooth. Methodological quality: assessed by PEDro score. Effect sizes: calculate

APA, Harvard, Vancouver, ISO, and other styles

3

Shnayder, N. A., Ye V. Gluschenko, and Ye A. Kozulina. "Evaluation of life quality in patients with hereditary neuropathy Charcot—Marie—Tooth in the Krasnoyarsk Region." Bulletin of Siberian Medicine 10, no. 2 (2011): 57–62. http://dx.doi.org/10.20538/1682-0363-2011-2-57-62.

Full text

Abstract:

To assess the life quality in patients with hereditary neuropathy Charcot—Marie—Tooth in the Krasnoyarsk Region. Life quality was assessed in 28 patients with confirmed diagnosis of hereditary neuropathy Charcot—Marie—Tooth, using the «EuroQuality of Life — 5 Dimention», Rankin scale. A significant decline in the quality of life in patients with hereditary neuropathy Charcot—Marie—Tooth suggests the need to develop strategies for their physical, medical and social rehabilitation.

APA, Harvard, Vancouver, ISO, and other styles

4

Young, P., and B. Dräger. "Charcot-Marie-Tooth-Erkrankungen." Nervenheilkunde 36, no. 01/02 (2017): 56–60. http://dx.doi.org/10.1055/s-0038-1635137.

Full text

Abstract:

ZusammenfassungDie Gruppe der hereditären Neuropathien (Charcot-Marie-Tooth-Erkrankungen, CMT) ist eine klinisch und genetisch heterogene Gruppe von peripheren Neuropathien. Die Prävalenz beträgt 1:2 500, womit die CMT zu den seltenen Erkrankungen zählen. In der klinischen Neurologie stellen sie die häufigste neurogenetische Erkrankung dar. Die CMTFormen mit sensiblen und motorischen Symptomen sind am häufigsten. Neben diesen Formen gibt es rein sensible Formen, mit oder ohne autonome Symptome (HSAN), rein motorische Neuropathien (dHMN) und die besondere Form der hereditären Neuropathie mit Ne

APA, Harvard, Vancouver, ISO, and other styles

5

Berciano, J., and J. Calleja. "Charcot-Marie-Tooth disease." Neurology 44, no. 10 (1994): 1985. http://dx.doi.org/10.1212/wnl.44.10.1985-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Garcia, C. A., D. A. Kaku, G. J. Parry, and J. R. Lupski. "Charcot-Marie-Tooth disease." Neurology 44, no. 10 (1994): 1986. http://dx.doi.org/10.1212/wnl.44.10.1986.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Chetlin, R. D., R. A. Yeater, I. H. Ullrich, L. A. DeChristopher, and L. Gutmann. "CHARCOT-MARIE-TOOTH DISEASE." Medicine & Science in Sports & Exercise 34, no. 5 (2002): S230. http://dx.doi.org/10.1097/00005768-200205001-01287.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Reilly, Mary M., Sinéad M. Murphy, and Matilde Laurá. "Charcot-Marie-Tooth disease." Journal of the Peripheral Nervous System 16, no. 1 (2011): 1–14. http://dx.doi.org/10.1111/j.1529-8027.2011.00324.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Casasnovas, Carlos, Luis Miguel Cano, Antonia Albertí, Maria Céspedes, and Gillem Rigo. "Charcot-Marie-Tooth Disease." Foot & Ankle Specialist 1, no. 6 (2008): 350–54. http://dx.doi.org/10.1177/1938640008326247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Casasnovas, C., L. M. Cano, A. Alberti, M. Cespedes, and G. Rigo. ": Charcot-Marie-Tooth Disease." Foot & Ankle Specialist 1, no. 6 (2008): 350–54. http://dx.doi.org/10.1177/1938640008326247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Howcroft, D. W. J., S. Kumar, and N. Makwana. "Charcot Marie Tooth Disease." Orthopaedics and Trauma 23, no. 4 (2009): 274–77. http://dx.doi.org/10.1016/j.mporth.2009.04.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Manganelli, Fiore, Maria Nolano, Chiara Pisciotta, et al. "Charcot-Marie-Tooth disease." Neurology 85, no. 14 (2015): 1202–8. http://dx.doi.org/10.1212/wnl.0000000000001993.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Quadros Santos Monteiro Fonseca, Alulin Tácio, and Edmar Zanoteli. "Charcot-Marie-Tooth disease." Revista Médica Clínica Las Condes 29, no. 5 (2018): 521–29. http://dx.doi.org/10.1016/j.rmclc.2018.06.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Koeppen, Arnulf H. "Charcot-Marie-Tooth disorders." Journal of the Neurological Sciences 182, no. 2 (2001): 171–72. http://dx.doi.org/10.1016/s0022-510x(00)00457-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Szigeti, Kinga, and James R. Lupski. "Charcot–Marie–Tooth disease." European Journal of Human Genetics 17, no. 6 (2009): 703–10. http://dx.doi.org/10.1038/ejhg.2009.31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Carter, Gregory T., Michael D. Weiss, Jay J. Han, Phillip F. Chance, and John D. England. "Charcot-Marie-Tooth disease." Current Treatment Options in Neurology 10, no. 2 (2008): 94–102. http://dx.doi.org/10.1007/s11940-008-0011-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Chance, P. F., and D. Pleasure. "Charcot-Marie-Tooth Syndrome." Archives of Neurology 50, no. 11 (1993): 1180–84. http://dx.doi.org/10.1001/archneur.1993.00540110060006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Smith, A. Gordon. "Charcot-Marie-Tooth Disease." Archives of Neurology 58, no. 6 (2001): 1014. http://dx.doi.org/10.1001/archneur.58.6.1014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sidelkovskyi, O. L., T. V. Hasiuk, V. V. Chechotenko, and O. Yu Rybalko. "Clinical markers of Charcot-Marie-Tooth disease (own experience)." INTERNATIONAL NEUROLOGICAL JOURNAL 20, no. 5 (2024): 250–52. http://dx.doi.org/10.22141/2224-0713.20.5.2024.1093.

Full text

Abstract:

Charcot-Marie-Tooth disease is also called hereditary motor and sensory neuropathy. It is a genetically determined disease that has different variants of inheritance whose substratum is neuromuscular disorders. It may begin during childhood or later in life. Scientists have identified and described more than thirty genetic mutations that form an individual unique passport of violations of the sequence of a group of organic compounds or nucleotides in nucleic acid molecules. There are autosomal dominant, autosomal recessive and X-linked types of genetic inheritance of Charcot-Marie-Tooth diseas

APA, Harvard, Vancouver, ISO, and other styles

20

Sun, Shun-Chang, Di Ma, Mei-Yi Li, et al. "Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease." Brain 142, no. 8 (2019): 2215–29. http://dx.doi.org/10.1093/brain/awz151.

Full text

Abstract:

Abstract Charcot-Marie-Tooth disease is a hereditary motor and sensory neuropathy exhibiting great clinical and genetic heterogeneity. Here, the identification of two heterozygous missense mutations in the C1orf194 gene at 1p21.2-p13.2 with Charcot-Marie-Tooth disease are reported. Specifically, the p.I122N mutation was the cause of an intermediate form of Charcot-Marie-Tooth disease, and the p.K28I missense mutation predominately led to the demyelinating form. Functional studies demonstrated that the p.K28I variant significantly reduced expression of the protein, but the p.I122N variant incre

APA, Harvard, Vancouver, ISO, and other styles

21

Dr., Hassan Jazayeri. "Charcot Marie Tooth (CMT) Syndrome A Very Rare Neuro-Genetical Diseases." MAR Neurology, Neurosurgery & Psychology 7, no. 3 (2023): 15. https://doi.org/10.5281/zenodo.8429497.

Full text

Abstract:

<strong>As a preface:</strong> Despite working experience of more than thirty years in the field of neurology and psychology, I have never encountered the case that I would like to introduce to you. Charcot Marie Tooth.  A syndrome that is basically found in textbooks and sometimes neurologists face it from time to time. I chose this report because, for me, the process of diagnosing and confirming this disease, despite the fact that he was my patient for years, we had not paid attention to this issue.   <strong>What is Charcot Marie Tooth (CMT) Syndrome?    </strong> C

APA, Harvard, Vancouver, ISO, and other styles

22

Nakagawa, Masanori. "Diagnosis and care of Charcot-Marie-Tooth disease." Rinsho Shinkeigaku 54, no. 12 (2014): 950–52. http://dx.doi.org/10.5692/clinicalneurol.54.950.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Wegener, Caleb, Katrin Wegener, Richard Smith, Karl-Heinz Schott, and Joshua Burns. "Biomechanical effects of sensorimotor orthoses in adults with Charcot–Marie–Tooth disease." Prosthetics and Orthotics International 40, no. 4 (2015): 436–46. http://dx.doi.org/10.1177/0309364615579318.

Full text

Abstract:

Background: Charcot–Marie–Tooth disease is an inherited neuropathy causing progressive weakness, foot deformity and difficulty walking. Clinical anecdotes suggest orthoses designed on the ‘sensorimotor’ paradigm are beneficial for improving gait in Charcot–Marie–Tooth disease. Objectives: Investigate the effect of sensorimotor orthoses on in-shoe and lower limb biomechanics in adults with Charcot–Marie–Tooth disease. Study design: Randomised, repeated-measures, exploratory study. Methods: Eight males and two females with Charcot–Marie–Tooth disease aged 31–68 years fitted with pedorthic shoes

APA, Harvard, Vancouver, ISO, and other styles

24

Murtazina, A. F., O. A. Shchagina, T. B. Milovidova, et al. "Clinical and genetic characteristics of Charcot–Marie–Tooth disease type 4D (type Lom) in Russia." Neuromuscular Diseases 10, no. 2 (2020): 39–45. http://dx.doi.org/10.17650/2222-8721-2020-10-2-39-45.

Full text

Abstract:

Introduction. Charcot–Marie–Tooth disease type 4D is a hereditary demyelinating neuropathy, that occurs with the high frequency in patients of Roma origin. It is characterized by early onset at the age of 2–10 years and hearing impairment, manifested by the 3rd decade of life.Aim of the study. To describe the clinical and genetic characteristics of Charcot–Marie–Tooth disease type 4D in Russian patients of Roma origin.Materials and methods. For 14 probands from unrelated families of Roma origin with a clinical diagnosis of Charcot–Marie–Tooth disease, genetic tests for the pathogenic variants

APA, Harvard, Vancouver, ISO, and other styles

25

Fiacchino, Folco, Laura Grandi, Claudia Ciano, and Angelo Sghirlanzoni. "Unrecognized Charcot-Marie-Tooth Disease." Anesthesia & Analgesia 81, no. 1 (1995): 199–201. http://dx.doi.org/10.1097/00000539-199507000-00043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Sautreuil, Patrick, Delphine Delorme, Anne Baron, Michèle Mane, Besma Missaoui, and Philippe Thoumie. "Maladie de Charcot-Marie-Tooth." médecine/sciences 33 (November 2017): 49–54. http://dx.doi.org/10.1051/medsci/201733s110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Fiacchino, Folco, Laura Grandi, Claudia Ciano, and Angelo Sghirlanzoni. "Unrecognized Charcot-Marie-Tooth Disease." Anesthesia & Analgesia 81, no. 1 (1995): 199–201. http://dx.doi.org/10.1213/00000539-199507000-00043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Jani-Acsadi, Agnes, Sylvia Ounpuu, Kristan Pierz, and Gyula Acsadi. "Pediatric Charcot-Marie-Tooth Disease." Pediatric Clinics of North America 62, no. 3 (2015): 767–86. http://dx.doi.org/10.1016/j.pcl.2015.03.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Shy, Michael E., and Ágnes Patzkó. "Axonal Charcot–Marie–Tooth disease." Current Opinion in Neurology 24, no. 5 (2011): 475–83. http://dx.doi.org/10.1097/wco.0b013e32834aa331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Rasic, V. Milic, S. Todorovic, E. Nelis, M. Keckarevic, L. Kalaydjieva, and V. Brankovic. "NMP08 Asymptomatic Charcot Marie Tooth." European Journal of Paediatric Neurology 11 (September 2007): 73. http://dx.doi.org/10.1016/s1090-3798(08)70526-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Liu, Lei, and Ruxu Zhang. "Intermediate Charcot-Marie-Tooth disease." Neuroscience Bulletin 30, no. 6 (2014): 999–1009. http://dx.doi.org/10.1007/s12264-014-1475-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Lupski, James R. "Recessive Charcot-Marie-Tooth disease." Annals of Neurology 47, no. 1 (2000): 6–8. http://dx.doi.org/10.1002/1531-8249(200001)47:1<6::aid-ana4>3.0.co;2-u.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Nau, Jean-Yves. "Dyslexies ; Charcot-Marie-Tooth ; réductionnisme." Revue Médicale Suisse 8, no. 323 (2012): 74–75. http://dx.doi.org/10.53738/revmed.2012.8.323.0074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Rybalko, Lina, Liudmyla Kletsenko, Yevheniia Vyshar, et al. "Application of kinesitherapy within the process of rehabilitation of patients with Charcot-Marie-Tooth nerval amyotrophia." European Journal of Clinical and Experimental Medicine 21, no. 1 (2023): 169–79. http://dx.doi.org/10.15584/ejcem.2023.1.22.

Full text

Abstract:

Introduction and aim. Researching inherited polyneuropathy is vastly topical in the course of the contemporary practice of physical therapy and ergotherapy. The article unveils the results of the application of kinesitherapy in the process of rehabilitation of patients with Charcot-Marie-Tooth nerval amyotrophia. Inherited Charcot-Marie-Tooth neuropathy is a genetical disease, which is manifested with the slow reduction of the size of muscles of limbs and weakening of distal locations, is the most widespread clinical form of inherited polyneuropathies, which affect people regardless of generat

APA, Harvard, Vancouver, ISO, and other styles

35

Pozdnikin, Ivan Yurievich. "Dysfunction in the hip joints in children with Charcot-Marie-Tooth syndrome (literature review)." Pediatric Traumatology, Orthopaedics and Reconstructive Surgery 3, no. 3 (2015): 52–56. http://dx.doi.org/10.17816/ptors3352-56.

Full text

Abstract:

A review of the literature on the treatment of children with dysfunction in the hip joints in motor-sensory neuropathy Charcot-Marie-Tooth is presented. Peculiarities of disease diagnosis and the approach used in the treatment of patients are described. The Charcot-Marie-Tooth syndrome is a hereditary neuromuscular disease characterized by progressive atrophy of the distal muscle group of the lower limbs. According to international authors, the incidence of hip joint dysfunction in this condition is at least 10%, ranking second only to foot deformities. In the Russian literature, the problem h

APA, Harvard, Vancouver, ISO, and other styles

36

Mosawi, Aamir Jalal Al. "A Review The use of Cerebrolysin in Pediatric Charcot Marie Tooth Disease." Journal of Neurological Research and Therapy 3, no. 2 (2020): 13–17. http://dx.doi.org/10.14302/issn.2470-5020.jnrt-20-3226.

Full text

Abstract:

Charcot Marie Tooth disease is a is a very chronic progressive hereditarymotor and sensory neuropathy characterized by progressive weakness andloss of touch sensation across various parts of the body. There are no curative or effective medical therapies that can ameliorate the disability associated with Charcot Marie Tooth disease. The aim of this paper is to describe the safe novel use of cerebrolysin in an Iraqi patient with Charcot Marie Tooth disease. Patients and Methods A boy who was born on the seventh of November, 2009, and was first seen on 29th of January, 2018 at the Children Teachi

APA, Harvard, Vancouver, ISO, and other styles

37

Menotti, Federica, Luca Laudani, Antonello Damiani, Teresa Mignogna, and Andrea Macaluso. "An anterior ankle-foot orthosis improves walking economy in Charcot–Marie–Tooth type 1A patients." Prosthetics and Orthotics International 38, no. 5 (2013): 387–92. http://dx.doi.org/10.1177/0309364613506250.

Full text

Abstract:

Background: Ankle-foot orthoses are commonly prescribed in Charcot–Marie–Tooth type 1A disease to improve quality of walking and reduce the risk of falling due to the foot drop. Objectives: This study aimed at assessing the effect of an anterior ankle-foot orthosis on walking economy in a group of Charcot–Marie–Tooth type 1A patients. Study design: Within-group comparisons. Methods: 7 Charcot–Marie–Tooth type 1A patients (four women and three men; 37 ± 11 years; age range = 22–53 years) were asked to walk on a circuit at their self-selected speeds (‘slow’, ‘comfortable’ and ‘fast’) in two walk

APA, Harvard, Vancouver, ISO, and other styles

38

Neagoe, Ioana Cristina. "Aspects Concerning Physical Therapy’s Role in Helping the Patient Suffering From Charcot-Marie-Tooth Disease Recover." GYMNASIUM XXI, no. 2 (2020): 51. http://dx.doi.org/10.29081/gsjesh.2020.21.2.03.

Full text

Abstract:

Charcot-Marie-Tooth disease is a heterogenous group of genetic disorders, presenting the phenotype of a chronic progressive neuropathy affecting both the motor nerves, and thesensitive ones. The disease generally develops before the age of 20 years in the lower limbs. The evolution is chronic and progresses slowly. Charcot-Marie-Tooth disease is one of most commonly inherited neurological disorders, affecting about one in 2,500 people in the United States and 2,8 million people around the world. The present paper intends to be a contribution to improving kinetic treatment programme for Charcot

APA, Harvard, Vancouver, ISO, and other styles

39

Meneghetti, Cristiane Helita Zorél, Miriam Tonon de Meira, Sofia Poletti, Ana Carolina Teixeira Batistela, and Luiz Carlos Ferracini Junior. "Influência da Hipoterapia no Equilíbrio Estático em Um Indivíduo com Doença de Charcot-Marie-Tooth." Revista Neurociências 20, no. 3 (2001): 422–26. http://dx.doi.org/10.34024/rnc.2012.v20.8267.

Full text

Abstract:

Objetivo. Verificar a influência da hipoterapia no equilíbrio estático em um indivíduo com doença de Charcot-Marie-Tooth (CMT). Método. Foi realizado um estudo de caso, com uma participante com doença de Charcot-Marie-Tooth, gênero feminino, 12 anos de idade. A participante foi filmada na vista anterior (plano frontal) e perfil (plano sagital). O instrumento utilizado foi a Biofotogrametria Computadorizada que serviu como referência angular para verificar as oscilações do corpo em equilíbrio estático. A intervenção da hipoterapia foi realizada durante 16 sessões, duas vezes por semana, num

APA, Harvard, Vancouver, ISO, and other styles

40

Abdul, Temilola Y., Andrew E. Schneider, Frank Cetta, and David J. Driscoll. "Fontan Failure Secondary to Charcot-Marie-Tooth–Induced Phrenic Neuropathy." Texas Heart Institute Journal 45, no. 4 (2018): 270–72. http://dx.doi.org/10.14503/thij-17-6337.

Full text

Abstract:

Charcot-Marie-Tooth disease comprises a vast array of defects in myelin integrity that causes progressive peripheral sensorimotor neuropathy. It is the most prevalent inherited peripheral neuropathy, and it can affect the management of coexisting medical conditions. We report the case of a 25-year-old woman who had undergone successful Fontan surgery during childhood, but her Fontan circulation failed as a result of diaphragmatic paresis caused by Charcot-Marie-Tooth disease type 1A. This diagnosis precluded cardiac transplantation.

APA, Harvard, Vancouver, ISO, and other styles

41

Bensoussan, Laurent, Arnaud Jouvion, Marjorie Kerzoncuf, et al. "Orthopaedic shoes along with physical therapy was effective in Charcot-Marie-Tooth patient over 10 years." Prosthetics and Orthotics International 40, no. 5 (2016): 636–42. http://dx.doi.org/10.1177/0309364615584657.

Full text

Abstract:

Background: The aim was to investigate the effectiveness of custom-made orthopaedic shoes (derby shoes) along with physiotherapy (twice a week) on a person with Charcot-Marie-Tooth over a period of 10 years. Case description and methods: A 66-year-old woman with Charcot-Marie-Tooth disease, who did not have other health conditions, complained of pain and frequent falls. Physical examination, including ankle, knee and hip muscle strength; sensory evaluation of foot and joint range of motion; self-reported assessment of pain, frequency of falls and sprains; and gait analyses, including spatial a

APA, Harvard, Vancouver, ISO, and other styles

42

Orejana-García, Ángel M., Javier Pascual-Huerta, and Andrés Pérez-Melero. "Charcot-Marie-Tooth Disease and Vincristine." Journal of the American Podiatric Medical Association 93, no. 3 (2003): 229–33. http://dx.doi.org/10.7547/87507315-93-3-229.

Full text

Abstract:

This article reports on a case of sensorimotor neuropathy in a 55-year-old man that developed after vincristine therapy. Subsequent biopsy of the sural nerve and electromyographic studies revealed the presence of Charcot-Marie-Tooth disease. Only 17 patients who developed severe neuropathy with very low accumulated doses of vincristine have been described in the literature. Pain and lateral ankle instability were treated with a functional orthosis. Orthopedic treatment and the biomechanical basis of foot and ankle problems in patients with vincristine therapy–induced Charcot-Marie-Tooth diseas

APA, Harvard, Vancouver, ISO, and other styles

43

Wissing, Fabian R., Seung-Min Ryu, and Henrik Menke. "Metatarsale Exostose bei Charcot-Marie-Tooth Syndrom Typ I." Handchirurgie · Mikrochirurgie · Plastische Chirurgie 50, no. 02 (2018): 149–51. http://dx.doi.org/10.1055/s-0043-112130.

Full text

Abstract:

Erstmals von Charcot und Marie 1886 in Paris beschrieben und später von Tooth in London, ist das Charcot-Marie-Tooth Syndrom (CMT) die häufigste vererbte Erkrankung des peripheren Nervensystems und tritt mit einer Prävalenz von 1 : 2500 auf. Die klinisch und genetisch heterogene Erkrankung ist u. a. gekennzeichnet durch Auftreten in der 1.–2. Lebensdekade, familiäre Häufung, gering bis mäßig ausgeprägte Sensibilitätsstörung und eine langsam progrediente Muskelschwäche, welche meist in den Beinen beginnt und dann in die obere Extremität fortschreitet 1, 2, 3.

APA, Harvard, Vancouver, ISO, and other styles

44

Kubo, Satoki, and Mayo Nunokawa. "Effectiveness of a multimodal treatment approach for a woman in her 60s with Charcot-marie-tooth disease and scoliosis." MOJ Sports Medicine 6, no. 3 (2023): 105–7. http://dx.doi.org/10.15406/mojsm.2023.06.00150.

Full text

Abstract:

Charcot-Marie-Tooth disease, also known as hereditary peripheral neuropathy, is a rare disorder that causes muscle atrophy and sensory abnormalities. The disease can cause many difficulties in the patient's daily life, especially as muscle atrophy and deformity progresses, making it difficult to walk and maintain balance. This study details the effects of treatment on a woman in her 60s with Charcot-Marie-Tooth disease and severe scoliosis. The treatment approach incorporated a multifaceted approach of increasing skin mobility and range of motion, eliminating catastrophic thoughts, reducing mu

APA, Harvard, Vancouver, ISO, and other styles

45

&NA;. "Onapristone for Charcot-Marie-Tooth disease?" Inpharma Weekly &NA;, no. 1422 (2004): 9. http://dx.doi.org/10.2165/00128413-200414220-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Millichap, J. Gordon. "Genetics of Charcot-Marie-Tooth Disease." Pediatric Neurology Briefs 12, no. 5 (1998): 37. http://dx.doi.org/10.15844/pedneurbriefs-12-5-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Millichap, J. Gordon. "Early Onset Charcot-Marie-Tooth Disease." Pediatric Neurology Briefs 19, no. 6 (2005): 43. http://dx.doi.org/10.15844/pedneurbriefs-19-6-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Stassart, Ruth M., Robert Fledrich, Michael W. Sereda, and Michael Bartl. "Aktuelles zur Charcot-Marie-Tooth-Erkrankung." Nervenheilkunde 38, no. 06 (2019): 389–96. http://dx.doi.org/10.1055/a-0883-9906.

Full text

Abstract:

ZUSAMMENFASSUNGDie Charcot-Marie-Tooth-Erkrankung (CMT) ist die häufigste hereditäre Neuropathie (Prävalenz 1:2500) mit über 90 assoziierten Genen. Der häufigste Subtyp (CMT1A), assoziiert mit einer Duplikation des peripheren Myelinprotein-22-Gens (PMP22) ist Ursache für 40–50 % aller Fälle. Klinische Zeichen sind distal symmetrische Paresen, Atrophien, Sensibilitätsstörungen, Fußdeformitäten und Areflexie. Validierte Skalen zur Evaluation der Beeinträchtigung (CMTNS2, ONLS, 9-hole-pegtest, Gehtestungen) sind verfügbar und molekulare Biomarker aus Blut und Hautbiopsien wurden validiert. Therap

APA, Harvard, Vancouver, ISO, and other styles

49

Vallat, Jean-Michel, Meriem Tazir, Corinne Magdelaine, Franck Sturtz, and Djamel Grid. "Autosomal-Recessive Charcot-Marie-Tooth Diseases." Journal of Neuropathology & Experimental Neurology 64, no. 5 (2005): 363–70. http://dx.doi.org/10.1093/jnen/64.5.363.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Shy, Michael E. "Charcot-Marie-Tooth disease: an update." Current Opinion in Neurology 17, no. 5 (2004): 579–85. http://dx.doi.org/10.1097/00019052-200410000-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!